Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study
A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
|3||Active, not recruiting||
Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
† Study has passed its completion date and status has not been verified in more than two years.